Firefly Neuroscience, Inc. (AIFF)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Firefly Neuroscience, Inc. (AIFF) is up 56.6% since the beginning of the year. At $1 per share, AIFF is trading 62.3% below its 52-week high of $4. Investors who bought $1,000 worth of AIFF shares 5 years ago would now be looking at an investment worth $15.

Firefly Neuroscience, Inc. (AIFF) has returned 56.57% so far this year and -54.33% over the past 12 months. Over the last ten years, AIFF has returned -11.21% per year, falling short of the S&P 500 Index benchmark, which averaged 13.67% annually.

Based on dividend-adjusted daily data since Feb 23, 2011, AIFF's average daily return is +0.27%, while the average monthly return is +2.82%. At this rate, an investment would double in approximately 2.1 years.

Historically, 36% of months were positive and 64% were negative. The best month was Aug 2020 with a return of +261.1%, while the worst month was Mar 2023 at -62.4%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, AIFF closed higher 24% of trading days. The best single day was Feb 11, 2025 with a return of +171.0%, while the worst single day was Feb 14, 2025 at -41.7%.

Firefly Neuroscience, Inc. has an annualized alpha of 84.66%, beta of 0.50, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since February 23, 2011.

• This stock participated in 125.45% of S&P 500 Index downside but only 36.03% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.50 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

AIFF ranks 30 for risk / return — below 30% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Firefly Neuroscience, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Firefly Neuroscience, Inc. was 99.64%, occurring on Feb 23, 2026. The portfolio has not yet recovered.

The current Firefly Neuroscience, Inc. drawdown is 99.22%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Firefly Neuroscience, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Firefly Neuroscience, Inc. is priced in the market compared to other companies in the Software - Application industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.